NCT05860569View on ClinicalTrials.gov

Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions

Hypertriglyceridemia, Familial

Interventions

GENETIC

GC304

Self-complementary adeno-associated virus serotype 5 (AAV5) carrying a codon-optimized LPL coding sequence(coLPL) driven by a liver-specific promoter (LP)

Trial Locations (1)

Unknown

RECRUITING

Peking Union Medical College, Beijing

All Listed Sponsors

lead

GeneCradle Inc

INDUSTRY